Adtralza
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Adtralza, covering 2025-01-16 to 2026-04-07. Get the full timeline:
Most recent: EMA Authorised: Adtralza (tralokinumab) — LEO Pharma A/S
2 regulatory and trial events tracked for Adtralza, covering 2025-01-16 to 2026-04-07. Get the full timeline:
Most recent: EMA Authorised: Adtralza (tralokinumab) — LEO Pharma A/S